Each treatment option has its benefits and risks, and the choice should be tailored to the individuals needs, preferences, and medical history
The D-isomer has pharmacologic effects but does not participate in lipid metabolism
Clin Liver Dis 12(4):769790 Volpe S, Lisco G, Fanelli M, Racaniello D, Colaianni V, Triggiani D, Donghia R, Crudele L, Rinaldi R, Sabb C (2022) Once-weekly subcutaneous semaglutide improves fatty liver disease in patients with type 2 diabetes: a 52-week prospective real-life study
Backed by clinical studies, such as those by Leyden et al
Persistent vomiting or signs of dehydration also warrant prompt review